AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
2
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
3
Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers
4
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
5
Prompt Security raises $18 million Series A to protect enterprises from GenAI risks
More news

Biopharmaceutical

7 stories about Biopharmaceutical
וירוס וירוסים חיידק חיידקים בקטריות

Biomica raises $20 million for microbiome-based therapeutics

22.12.22|CTech
The Israeli company's drug candidates are based on a rationally designed consortia of microbes, selected through high-resolution functional microbiome analysis
Pitango HealthTech Fund: Ittai Harel (left), Managing Partner; Maya Perl, Principal; Guy Ezekiel,

250 companies and $6.5 billion: An in-depth look at Israel’s healthtech industry

27.08.20|Maya Perl, Ittai Harel, Guy Ezekiel
Israeli healthcare startups are no longer relying solely on technology, clinical data, or IP to generate value. They are reinventing business models and elevating the industry.
עובדים ב מפעל של קמהדע

Israeli company Kamada to offer antibody treatment to Covid-19 patients

17.06.20|Hagar Ravet
“To the best of our knowledge, Kamada is the first company globally to complete manufacturing of a plasma-derived IgG product for the treatment of Covid-19,” says CEO of the Nasdaq listed company
ענת כהן-דייג מנכ"לית קומפיוג'ן

Bristol-Myers Squibb Invests $12 Million in Israeli Immunotherapy Company Compugen

12.10.18|Dror Reich
The investment is part of a clinical trial collaboration for a treatment that combines Compugen’s investigational antibody with an immune checkpoint inhibitor from Bristol-Myers Squibb
default image

Pineapple Burn Treatment Company Receives Up to $43 Million in U.S. Funding

27.09.18|Amarelle Wenkert
Israeli biopharmaceutical company MediWound is awarded a new contract by the U.S. Department of Health and Human Services to advance the use of pineapple treatment for sulfur mustard injuries
פיטר ת'יל יזם ו משקיע בתחום ה הייטק

Peter Thiel Invests in Israeli Biopharmaceutical Startup ChemomAb

04.12.17|Meir Orbach
ChemomAb develops an antibody treatment for inflammatory and fibrotic diseases
default image

Pontifax Leads $9.5 Funding Round for Biopharmaceutical Company ArQule

19.11.17|CTech
Nasdaq-listed ArQule develops treatments for cancer and rare diseases